Good Day BIO Newsletter

This week, we unpack BIO’s priorities for the 119th Congress and take a deep dive into recently reintroduced legislation that would support the development of sustainable aviation fuel. (730 words, 3 minutes, 39 seconds)

As the new Trump administration begins in freezing-cold Washington, we look at the FTC’s new report on PBMs, what to know about Medicare Part D changes, what happened at JPM Week, and much more. (862 words, 4 minutes, 18 seconds)

BIO experts weigh in on what to expect during JPM Week and how biotech could boost the economy. Plus, BIO’s John Crowley joined the White House Cell and Gene Therapy Forum last week. (646 words, 3 minutes, 13 seconds).Due to Martin Luther King Jr. Day and Inauguration Day on Monday, January 20, we will publish our next edition on Tuesday, January 21.

Welcome back, and Happy 2025. We kick off the new year with a look back at some news you might have missed during the break: USMCA dispute panel halted Mexico’s biotech corn ban, what happened with the PPRV, and the latest news on avian flu. (755 words, 3 minutes, 46 seconds)

Before we head out for the holidays, we're back with some breaking news about a few of BIO's legislative priorities. Happy Holidays and Happy New Year! We'll see you in 2025 (unless there's major breaking news over the break). (566 words, 2 minutes, 49 seconds)

A busy Monday brings louder calls for PBM reform, plus a report on U.S. biotech economic output and jobs, news on avian flu and plant biotech regulations, and more. (834 words, 4 minutes, 10 seconds)

Hope you enjoyed the holiday weekend. We’re back with BIO’s Bio.News series on the problems with PBMs, plus a recap of BIO’s IP Counsels Committee Conference and more news you need to know. (573 words, 2 minutes, 51 seconds)

Before you begin your Thanksgiving prep, we recap last week's Clinical Trial Diversity Summit, how the "faceless middleman" is raising your healthcare costs, and promising news from USDA. (890 words, 4 minutes, 27 seconds)

A busy week in Washington begins, and we recap what you need to know about COP29, antimicrobial resistance, and more news on infectious disease. (1050 words, 5 minutes, 15 seconds)

Today, we explore BIO’s recommendations for how CMS can safeguard patient access under Medicare Part D, along with insights on a California Supreme Court case that could affect the complex drug development process, plus more news to know. (748 words, 3 minutes, 44 seconds).As we observe Veterans Day, we honor America’s veterans for their service and sacrifice. Check out our past coverage on how biotech supports veterans and ways to advocate for women veterans.